Thymogam® (Anti-Thymocyte Globulin (Equine))

Thymogam® (Anti-Thymocyte Globulin (Equine)) Anti-thymocyte globulin (equine) 250 mg / 5 mL injection by Bharat Serums and Vaccines. Genuine stock supplied in bulk/wholesale quantities to hospitals and pharmacies across India by A.K. Pharma, a licensed pharmaceutical distributor in Delhi.

Additional information

Composition

Anti-thymocyte globulin (equine) 250 mg / 5 mL

Manufacturer

Bharat Serums and Vaccines

Country

India

Pack size

Anti-thymocyte globulin (equine) 250 mg / 5 mL: 1 vial (as shown on the carton)

Storage

Refrigerate at 2°C to 8°C; do not freeze; protect from light.

Prescription medicine

Supplied only against a valid prescription from a registered medical practitioner.

100% genuine

Sourced from authorised channels

Cold-chain delivery

Temperature-controlled packing

Pan-India delivery

Hospitals, clinics, pharmacies

Licensed distributor

Delhi drug licence holder

Product information

Thymogam® (Anti-Thymocyte Globulin (Equine)) Anti-thymocyte globulin (equine) 250 mg / 5 mL Injection — Equine Anti-Thymocyte Globulin for Intravenous Use: A Sourcing Guide for Hospitals and Pharmacies

Thymogam® is a brand of anti-thymocyte globulin (equine) 250 mg per 5 mL for intravenous use, manufactured in India by Bharat Serums and Vaccines Limited, as shown on the carton. According to the current US prescribing information for the equine reference product Atgam, equine anti-thymocyte globulin is indicated for the management of allograft rejection in renal transplant patients and for the treatment of moderate to severe aplastic anemia in patients unsuitable for bone marrow transplantation. Indications in India are defined by its approved pack insert and the Indian regulator. The decision to prescribe anti-thymocyte globulin (equine), including patient selection, dose and monitoring, rests entirely with the treating physician. This page provides sourcing and procurement information for hospitals and pharmacies, not clinical or treatment guidance.

As both a trusted medicine distributor in Delhi and a licensed pharmaceutical distributor in Delhi, A.K. Pharma supplies genuine Thymogam® (anti-thymocyte globulin (equine)) Anti-thymocyte globulin (equine) 250 mg / 5 mL injection to hospitals and pharmacies across India. Buyers comparing pharmaceutical distribution companies and wholesale pharmaceutical distributors can also browse our full product range and the immunosuppressant medicines category. Supply is in bulk/wholesale quantities only.


What is Thymogam (Anti-Thymocyte Globulin (Equine))?

Thymogam contains anti-thymocyte globulin (equine) 250 mg in 5 mL, supplied in the pack size listed below.

How it works, according to the label: The reference label describes the product as an immunoglobulin G fraction obtained from horses immunised with human thymocytes, with immunosuppressive activity against T lymphocytes.


Indications as Listed in the Reference Label

The current US prescribing information for ATGAM® (lymphocyte immune globulin, anti-thymocyte globulin [equine]) injection (DailyMed) lists the following. Indications in India may differ and are defined by the Indian regulator and the Thymogam pack insert.

  • Management of allograft rejection in renal transplant patients
  • Treatment of moderate to severe aplastic anemia in patients unsuitable for bone marrow transplantation
  • Limitations of use are described in the label

Clinical Studies and Evidence

The reference label summarises its Clinical Studies in renal allograft rejection and aplastic anemia. A randomised comparison of horse versus rabbit antithymocyte globulin in acquired aplastic anemia was published by Scheinberg et al. in the New England Journal of Medicine in 2011. Evidence is cited for information only and is not a recommendation for any patient; the approved prescribing information governs.


Available Presentation

Strength Dosage form Pack size (as shown on the carton)
Anti-thymocyte globulin (equine) 250 mg / 5 mL Solution for intravenous use 1 vial (as shown on the carton)

Please confirm the current pack and batch with us before ordering. Dose and regimen must be determined and followed exactly as directed by the treating physician and the approved prescribing information.


Key Benefits for Procurement

  • Genuine, sealed original-pack stock sourced through authorised channels
  • Original manufacturer packaging with batch and expiry details
  • Batch and expiry details provided on request
  • Careful handling and storage of stock before dispatch
  • Documentation support for hospital purchase departments

Who Is This Page For?

This page is written for transplant centre and haematology department pharmacists and buyers and hospital pharmacies that source biologic immunosuppressant products. Anti-thymocyte globulin is administered under physician supervision, as described in the prescribing information.


Possible Side Effects Reported in the Label

The reference label carries a boxed warning for anaphylaxis. It lists pyrexia, chills, rash, thrombocytopenia, leukopenia and arthralgia among the most common adverse reactions (over 10%). This list is not complete; the full prescribing information governs.


Precautions

  • The reference label carries a boxed warning that anaphylaxis can occur and describes monitoring during infusion and afterwards.
  • The label advises that it should be used by physicians experienced in immunosuppressive therapy, in facilities with adequate laboratory and supportive resources.
  • The label describes allergy testing and the risk of serum sickness, as determined by the treating physician.
  • Administration and any dose decision follow the approved prescribing information and the treating physician.

All use should follow the approved prescribing information and the instructions of the treating physician.


Storage and Handling

Please follow the storage instructions printed on the Thymogam carton and vial. This is a refrigerated biologic; the US Atgam label describes storage in a refrigerator at 2°C to 8°C, in the original carton, and not frozen. Keep out of reach of children.


Manufacturer Information

Thymogam is marketed by Bharat Serums and Vaccines. A.K. Pharma is a licensed distributor and does not manufacture the product. As one of the pharmaceutical distributors serving Indian hospitals, we source Thymogam through authorised channels and supply it with pack and batch details. Buyers comparing a pharmaceutical wholesale distributors list or a pharma distribution company can verify our credentials on the About Us page.


Related Medicines


Frequently Asked Questions

Is Thymogam available in India?
A.K. Pharma supplies Thymogam (anti-thymocyte globulin (equine)) Anti-thymocyte globulin (equine) 250 mg / 5 mL injection to hospitals and pharmacies in India. Contact us for current availability.

What does Thymogam contain?
Anti-thymocyte globulin (equine), 250 mg in 5 mL, for intravenous use.

Can I order a single pack?
A.K. Pharma is a distributor and supplies bulk/wholesale quantities only, not one or two pieces.

How should Thymogam be stored?
Refrigerate at 2°C to 8°C in the original carton; do not freeze.

Does A.K. Pharma advise on dosing or suitability?
No. Treatment decisions, including dosing, rest solely with the treating physician and the approved prescribing information.

How do I request a quote?
Call or WhatsApp us, or use the contact details below.


Why Order from A.K. Pharma

  • Licensed pharmaceutical distributor in Delhi with 25+ years in specialty medicines
  • Genuine, original-pack stock
  • Bulk/wholesale supply to hospitals and pharmacies
  • Batch and expiry details on request
  • Dedicated team for hospital procurement queries

Sources and Further Reading


Contact A.K. Pharma for Thymogam Supply

📍 E-2/257A, 2nd Floor, Shastri Nagar, New Delhi 110052
📞 011 4172 6999
📱 WhatsApp: +91 9810034827
🌐 akpharma.in


Disclaimer: This page is intended for informational and sourcing/procurement purposes only and does not constitute medical or clinical advice. A.K. Pharma is a licensed medicine distributor, not a healthcare provider, and does not provide clinical guidance. All treatment decisions, including drug selection and dosing, rest solely with the treating physician and should follow the approved prescribing information.

Hi! 👋 Looking for a medicine? I can help you find it.

Quote Request Form


Quote Request Form